Recombinant Bovine Claudin-2 (CLDN2)

What is Claudin-2 and what is its primary function in cellular physiology?

Claudin-2 is a critical tight junction (TJ) protein that forms cation-selective pores between epithelial cells. While traditionally recognized for its role in regulating paracellular permeability, research has established that Claudin-2 has functions extending beyond simple barrier regulation. It participates in cellular signaling pathways that affect cell behavior, highlighting its multifunctional nature in tissue physiology . Understanding these broader functions is essential when using recombinant bovine Claudin-2 as a research tool to investigate tight junction biology.

What is the molecular weight of Claudin-2 protein and how does it compare between species?

The calculated molecular weight of human Claudin-2 is 25 kDa, with the observed molecular weight in Western blot analyses also being approximately 25 kDa . While bovine Claudin-2 may exhibit slight species-specific variations, the core structure and molecular weight remain relatively conserved across mammalian species. This conservation facilitates cross-species experimental approaches when working with the recombinant protein.

How does Claudin-2 interact with other claudin family members?

Claudin-2 exhibits specific heterotypic trans-interactions with other claudin family members. Research has demonstrated that Claudin-2 can bind to Claudin-3 on neighboring cells but does not interact with Claudin-1 . Additionally, an antagonistic relationship exists between Claudin-2 and both Claudin-4 and Claudin-8. Fluorescence recovery after photobleaching (FRAP) analysis revealed that Claudin-2 and Claudin-4 compete for residency at tight junctions, while Claudin-8 can displace Claudin-2 from junctions, resulting in elevated transepithelial resistance . These interaction patterns should be considered when designing experiments using recombinant bovine Claudin-2.

What are the recommended methods for detecting recombinant bovine Claudin-2 in experimental systems?

Several validated methods exist for detecting Claudin-2 protein:

• Western Blot (WB): The recommended dilution range is 1:500-1:2000 for antibodies targeting Claudin-2 . A standard protocol involves:

  • Loading 20-40 μg of cell lysate or 40 ng of recombinant Claudin-2

  • Separation on 4-12% Bis-Tris gels

  • Transfer to nitrocellulose membrane

  • Blocking with 4% milk powder

  • Primary antibody incubation overnight at 4°C

  • Detection with appropriate HRP-conjugated secondary antibodies

• Immunofluorescence (IF): For cellular localization studies, grow cells to confluence, fix with ice-cold methanol, block with 2% BSA, and incubate with anti-Claudin-2 primary antibody followed by fluorophore-conjugated secondary antibody .

• ELISA: Validated for quantitative detection of Claudin-2 expression levels .

How should recombinant bovine Claudin-2 protein be stored to maintain stability and activity?

Based on established protocols for Claudin-2 antibodies and proteins, the recommended storage conditions for recombinant bovine Claudin-2 are:

• Store at -20°C

• The protein remains stable for one year after shipment when properly stored

• Aliquoting is generally unnecessary for -20°C storage

• For buffer composition, PBS with 0.02% sodium azide and 50% glycerol at pH 7.3 is typically used

These conditions help maintain protein stability and prevent freeze-thaw cycles that could compromise functional integrity.

What cell lines or experimental models are most appropriate for studying recombinant bovine Claudin-2 function?

Several validated cell lines have demonstrated reliable Claudin-2 expression and are suitable for functional studies:

The choice of cell line should align with your specific research question, considering tissue origin and endogenous Claudin-2 expression levels.

How can the barrier function effects of recombinant bovine Claudin-2 be measured in cell culture models?

The gold standard for measuring Claudin-2-mediated changes in barrier function is transepithelial electrical resistance (TER). This involves:

• Growing epithelial cells (e.g., Caco-2) on permeable filter supports until confluence

• Allowing monolayers to differentiate for at least 14 days or until reaching TER values of ≥300 Ω·cm²

• Treating with recombinant Claudin-2 or experimental conditions

• Measuring TER using epithelial volt-ohm meters to detect changes in ionic permeability

Interestingly, despite Claudin-2 forming cation-selective pores, paradoxical effects have been observed where increased Claudin-2 expression does not necessarily decrease barrier function . These complex relationships should be considered when interpreting experimental results.

What signaling pathways are known to regulate Claudin-2 expression and function?

Several signaling pathways have been established to regulate Claudin-2 expression:

• Cytokine Regulation: TNFα has differential effects on Claudin-2 expression depending on treatment duration and cell type. In tubular and intestinal cell lines, short-term vs. long-term TNFα exposure produces opposite effects .

• Growth Factor Pathways: EGF affects the Claudin-2 promoter differently in Caco-2 colon cancer cells compared to MDCK tubular epithelial cells .

• TGF-β Signaling: Bovine colostrum increases TGF-β expression, which may compensate for increased Claudin-2 expression to maintain barrier integrity .

• CLDN2/ZO1/ZONAB Complex: In colorectal cancer research, CLDN2 depletion promotes N-myc downstream-regulated gene 1 (NDRG1) transcription by causing CLDN2/ZO1/ZONAB complex dissociation and ZONAB shuttle into the nucleus .

Understanding these pathways is crucial when designing experiments to modulate Claudin-2 function or expression using recombinant protein.

How can recombinant bovine Claudin-2 be utilized in studying inflammatory bowel disease (IBD) mechanisms?

Claudin-2 has emerged as a potential biomarker in IBD research, particularly in ulcerative colitis. Researchers have developed and validated an in situ hybridization assay for Claudin-2 suitable for use on formalin-fixed paraffin-embedded sections of colon biopsies . This approach allows for:

• Measurement of Claudin-2 expression in patient samples

• Correlation of expression levels with disease severity (Geboes score)

• Evaluation of target engagement in therapeutic trials

Using recombinant bovine Claudin-2 as a standard in these assays can help establish quantitative measurements and validate antibody specificity, critical for reliable biomarker development in translational IBD research .

What role does Claudin-2 play in cancer progression, and how might recombinant protein be used in oncology research?

Claudin-2 (CLDN2) has been implicated in colorectal cancer (CRC) progression through several mechanisms:

• CLDN2 is significantly upregulated in CRC samples and associated with poor patient survival

• CLDN2 depletion promotes NDRG1 transcription, inhibiting cancer growth and metastasis

• Mechanistically, CLDN2 knockdown promotes CLDN2/ZO1/ZONAB complex dissociation, resulting in ZONAB relocation to the nucleus

• This pathway regulates epithelial-mesenchymal transition (EMT) and expression of cyclin-dependent kinase inhibitors

Recombinant bovine Claudin-2 could be utilized in structural studies, protein-protein interaction assays, or as a competitive inhibitor to disrupt Claudin-2 complexes in cancer cells, potentially offering new therapeutic strategies targeting the CLDN2/ZO1/ZONAB-NDRG1 axis.

How do experimental variables affect Claudin-2 expression in cell culture systems?

Several critical variables influence Claudin-2 expression in experimental systems and should be carefully controlled:

• Cell Confluence: In LLC-PK1 tubular cells, Claudin-2 expression is low in subconfluent cultures and increases as confluence is established .

• Treatment Duration: The effect of cytokines like TNFα on Claudin-2 expression can be opposite depending on the length of treatment .

• Cell Passage Number: Expression patterns may change with increased passage of cell lines.

• Culture Conditions: Medium composition, supplements, and culture surfaces can significantly impact Claudin-2 expression and localization.

Researchers should standardize these variables and clearly report them to ensure experimental reproducibility when working with recombinant bovine Claudin-2.

What are the potential cross-reactivity concerns when using antibodies against recombinant bovine Claudin-2?

When detecting recombinant bovine Claudin-2, antibody cross-reactivity must be considered:

• Most commercially available antibodies have been validated for human, mouse, and rat Claudin-2 , but bovine reactivity should be specifically verified.

• The development and validation of target-specific antibodies for formalin-fixed samples is challenging, as published antibodies may not correctly identify the intended antigen in tissues fixed using standard methods .

• When selecting antibodies, confirm species reactivity and validation for your specific application (WB, IF, ELISA) and sample preparation method.

To minimize issues, include positive controls (such as recombinant human GST-tagged Claudin-2) in experimental protocols .

How can researchers distinguish between the effects of endogenous and recombinant bovine Claudin-2 in experimental systems?

To differentiate between endogenous and recombinant Claudin-2 effects:

• Tagged Recombinant Protein: Utilize recombinant bovine Claudin-2 with epitope tags (His, GST, FLAG) that allow specific detection separate from endogenous protein.

• Species-Specific Antibodies: When working across species barriers, use antibodies that specifically recognize bovine but not human/mouse Claudin-2.

• CRISPR/Cas9 Knockout Background: Generate Claudin-2 knockout cell lines where only the recombinant protein is present, eliminating background effects.

• Dose-Response Studies: Perform careful titration experiments with recombinant protein to distinguish concentration-dependent effects from endogenous background.

These approaches help establish causality between recombinant protein addition and observed experimental outcomes.